Life-threatening rituximab-induced pyoderma gangrenosum successfully treated with intravenous immunoglobulin.

Detalles Bibliográficos
Publicado en:Scandinavian Journal of Rheumatology Vol. 46; no. 5; pp. 413 - 415
Autores principales: Vikse, J, Rygh, A, Kaisen, K, Omdal, R
Formato: letter Journal Article
Publicado: Taylor & Francis Ltd Sep2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=125207467&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 125207467
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        03009742
        1GI
      jtl: Scandinavian Journal of Rheumatology
      issn: 03009742
      maglogo: Y
    pubinfo:
      dt: Sep2017
      vid: 46
      iid: 5
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        125207467
        125207467
        NLM27897446
        125207467
        10.1080/03009742.2016.1241298
        NLM27897446
        125207467
      ppf: 413
      ppct: 2
      formats:
      tig:
        atl: Life-threatening rituximab-induced pyoderma gangrenosum successfully treated with intravenous immunoglobulin.
      aug:
        au:
          Vikse, J
          Rygh, A
          Kaisen, K
          Omdal, R
        affil: Department of Medicine, Clinical Immunology Unit, Stavanger University Hospital, Stavanger, Norway
      sug:
        subj:
          Vaginal Diseases Physiopathology
          Granulomatosis with Polyangiitis Immunology
          Pyoderma Gangrenosum Etiology
          Vaginal Diseases Diagnosis
          Pyoderma Gangrenosum Physiopathology
          Granulomatosis with Polyangiitis Diagnosis
          Pyoderma Gangrenosum Therapy
          Pyoderma Gangrenosum Diagnosis
          Vaginal Diseases Therapy
          Granulomatosis with Polyangiitis Drug Therapy
          Immunoglobulins, Intravenous Administration and Dosage
          Vaginal Diseases Etiology
          Immunologic Factors Administration and Dosage
          Peritonitis Etiology
          Autoantibodies Immunology
          Autoantibodies Blood
          Female
          Respiration, Artificial Methods
          Respiratory Failure Therapy
          Immunologic Factors Adverse Effects
          Peritonitis Surgery
          Treatment Outcomes
          Biopsy Methods
          Respiratory Failure Diagnosis
          Peptide Hydrolases Immunology
          Methylprednisolone Administration and Dosage
          Antiinflammatory Agents Administration and Dosage
          Respiratory Failure Etiology
          Adult
          Peritonitis Diagnosis
          Adult: 19-44 years
          Female
      pubtype: Academic Journal
      doctype:
        letter
        Journal Article
      ougenre: Unknown
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N